1. Home
  2. GPRO vs SPRO Comparison

GPRO vs SPRO Comparison

Compare GPRO & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$1.32

Market Cap

154.6M

ML Signal

HOLD

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.77

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRO
SPRO
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.6M
135.5M
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
GPRO
SPRO
Price
$1.32
$2.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1M
425.0K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
79.08
111.81
EPS
N/A
0.15
Revenue
$651,542,000.00
$66,802,000.00
Revenue This Year
$23.14
N/A
Revenue Next Year
N/A
$300.00
P/E Ratio
N/A
$18.73
Revenue Growth
N/A
39.24
52 Week Low
$0.54
$0.58
52 Week High
$3.05
$3.09

Technical Indicators

Market Signals
Indicator
GPRO
SPRO
Relative Strength Index (RSI) 69.55 58.04
Support Level $1.17 $2.15
Resistance Level $1.57 $2.88
Average True Range (ATR) 0.15 0.13
MACD 0.05 0.01
Stochastic Oscillator 78.10 64.04

Price Performance

Historical Comparison
GPRO
SPRO

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: